Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $49.1 million.

  • Beam Therapeutics' Interest & Investment Income fell 10.09% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year decrease of 12.36%. This contributed to the annual value of $49.1 million for FY2024, which is 5.18% up from last year.
  • According to the latest figures from FY2024, Beam Therapeutics' Interest & Investment Income is $49.1 million, which was up 5.18% from $46.7 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Interest & Investment Income registered a high of $49.1 million during FY2024, and its lowest value of -$9,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $37.0 million, with a median of $46.7 million in 2023.
  • As far as peak fluctuations go, Beam Therapeutics' Interest & Investment Income crashed by 100.86% in 2021, and later spiked by 170,066.67% in 2022.
  • Over the past 5 years, Beam Therapeutics' Interest & Investment Income (Yearly) stood at $1.1 million in 2020, then tumbled by 100.86% to -$9,000 in 2021, then soared by 170,066.67% to $15.3 million in 2022, then surged by 205.13% to $46.7 million in 2023, then increased by 5.18% to $49.1 million in 2024.